Insights from 2023 ESMO Annual Meeting
ESMO 2023 Insights: "Efficacy & Safety Outcomes With Pembro Rechallenge for Patients With Advanced/Metastatic Urothelial Cancer Who Responded to First-Course Treatment"
By
Insights from 2023 ESMO Annual Meeting
FEATURING
Vadim Koshkin
By
Insights from 2023 ESMO Annual Meeting
FEATURING
Vadim Koshkin
Login to view comments.
Click here to Login
Genitourinary